178 related articles for article (PubMed ID: 31073374)
1. MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting
Simile MM; Peitta G; Tomasi ML; Brozzetti S; Feo CF; Porcu A; Cigliano A; Calvisi DF; Feo F; Pascale RM
Oncotarget; 2019 Apr; 10(29):2835-2854. PubMed ID: 31073374
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
3. Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.
Pascale RM; Peitta G; Simile MM; Feo F
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31234428
[TBL] [Abstract][Full Text] [Related]
4. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.
Lo TF; Tsai WC; Chen ST
PLoS One; 2013; 8(9):e75628. PubMed ID: 24098708
[TBL] [Abstract][Full Text] [Related]
6. S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis.
Tomasi ML; Cossu C; Spissu Y; Floris A; Ryoo M; Iglesias-Ara A; Wang Q; Pandol SJ; Bhowmick NA; Seki E; Posadas EM; Lu SC
Oncotarget; 2017 Oct; 8(45):78851-78869. PubMed ID: 29108270
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma.
Pascale RM; Feo CF; Calvisi DF; Feo F
Transl Gastroenterol Hepatol; 2018; 3():36. PubMed ID: 30050996
[TBL] [Abstract][Full Text] [Related]
8. Methionine adenosyltransferases in liver health and diseases.
Ramani K; Lu SC
Liver Res; 2017 Sep; 1(2):103-111. PubMed ID: 29170720
[TBL] [Abstract][Full Text] [Related]
9. Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics.
Nordgren KK; Peng Y; Pelleymounter LL; Moon I; Abo R; Feng Q; Eckloff B; Yee VC; Wieben E; Weinshilboum RM
Drug Metab Dispos; 2011 Nov; 39(11):2135-47. PubMed ID: 21813468
[TBL] [Abstract][Full Text] [Related]
10. MAT2A/2B promote porcine intramuscular preadipocyte proliferation through ERK signaling pathway.
Zhao C; Wu H; Chen P; Yi B; Ma Y; Deng K
Anim Sci J; 2019 Sep; 90(9):1278-1286. PubMed ID: 31293025
[TBL] [Abstract][Full Text] [Related]
11. Methionine adenosyltransferases in liver cancer.
Murray B; Barbier-Torres L; Fan W; Mato JM; Lu SC
World J Gastroenterol; 2019 Aug; 25(31):4300-4319. PubMed ID: 31496615
[TBL] [Abstract][Full Text] [Related]
12. MAT2B expression correlates with poor prognosis in triple-negative breast cancer.
Xu J; Wu D; Wang S; Wang Z
Cancer Manag Res; 2019; 11():5501-5511. PubMed ID: 31354356
[No Abstract] [Full Text] [Related]
13. Human Mat2A Uses an Ordered Kinetic Mechanism and Is Stabilized but Not Regulated by Mat2B.
Bailey J; Douglas H; Masino L; de Carvalho LPS; Argyrou A
Biochemistry; 2021 Nov; 60(47):3621-3632. PubMed ID: 34780697
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
15. Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma.
Martínez-Chantar ML; García-Trevijano ER; Latasa MU; Martín-Duce A; Fortes P; Caballería J; Avila MA; Mato JM
Gastroenterology; 2003 Apr; 124(4):940-8. PubMed ID: 12671891
[TBL] [Abstract][Full Text] [Related]
16. Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.
Maldonado LY; Arsene D; Mato JM; Lu SC
Exp Biol Med (Maywood); 2018 Jan; 243(2):107-117. PubMed ID: 29141455
[TBL] [Abstract][Full Text] [Related]
17. Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.
Tomasi ML; Ryoo M; Ramani K; Tomasi I; Giordano P; Mato JM; Lu SC
Oncotarget; 2015 Nov; 6(35):37706-23. PubMed ID: 26416353
[TBL] [Abstract][Full Text] [Related]
18. Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A.
Quinlan CL; Kaiser SE; Bolaños B; Nowlin D; Grantner R; Karlicek-Bryant S; Feng JL; Jenkinson S; Freeman-Cook K; Dann SG; Wang X; Wells PA; Fantin VR; Stewart AE; Grant SK
Nat Chem Biol; 2017 Jul; 13(7):785-792. PubMed ID: 28553945
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells.
Cai J; Mao Z; Hwang JJ; Lu SC
Cancer Res; 1998 Apr; 58(7):1444-50. PubMed ID: 9537246
[TBL] [Abstract][Full Text] [Related]
20. Structure and function study of the complex that synthesizes S-adenosylmethionine.
Murray B; Antonyuk SV; Marina A; Van Liempd SM; Lu SC; Mato JM; Hasnain SS; Rojas AL
IUCrJ; 2014 Jul; 1(Pt 4):240-9. PubMed ID: 25075345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]